LivSpek has developed a needle-free, optical method to measure blood constituents in real-time using Resonance Raman Spectroscopy through the conjunctiva. This technology is proprietary to LivSpek and the basis for its anticipated prototype, the SpekOne.
Diagnostic medicine has become one of the most important aspects of patient care. However, needles and labs are expensive, painful and time consuming, which limits patient affordability, comfort, and treatment
With advances in Biophotonics, poking patients with needles will soon be a thing in the past. LivSpek’s innovative approach to low-cost, hygienic, painless, and real-time blood analysis will advance global access to improved healthcare and diagnostics.
LivSpek is a medical device company focusing on non-invasive blood diagnostics. Through years of research, the company has developed proprietary technology to detect and measure blood components through the eye. Following the advances in biophotonics over the last decade, the intravenous approach to blood analysis has become outdated and is poised for replacement. LivSpek was founded in 2010 in Vancouver, Canada and is fully dedicated to revolutionizing the healthcare industry by providing faster, cheaper and painless solution.
Our founding team is supported by a diverse board of advisors, molecular biology, chemistry,
physics and engineering labs and a team of researchers, engineers and finance professionals.